{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:07:33Z","timestamp":1793369253880,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202876"],"award-info":[{"award-number":["82202876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC225"],"award-info":[{"award-number":["2023RC225"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ23H160046"],"award-info":[{"award-number":["LQ23H160046"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.gendis.2025.101796","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T02:42:51Z","timestamp":1754448171000},"page":"101796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors"],"prefix":"10.1016","volume":"13","author":[{"given":"Ping","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-7923","authenticated-orcid":false,"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gendis.2025.101796_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41573-020-00108-x","article-title":"Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease","volume":"20","author":"Bhat","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.gendis.2025.101796_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Targeted Ther"},{"issue":"7","key":"10.1016\/j.gendis.2025.101796_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"10.1016\/j.gendis.2025.101796_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.scib.2021.01.004","article-title":"A systematic survey of PRMT interactomes reveals the key roles of arginine methylation in the global control of RNA splicing and translation","volume":"66","author":"Wei","year":"2021","journal-title":"Sci Bull (Beijing)"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"10.1016\/j.gendis.2025.101796_bib6","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1093\/emboj\/cdf585","article-title":"Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs","volume":"21","author":"Meister","year":"2002","journal-title":"EMBO J"},{"issue":"Pt 9","key":"10.1016\/j.gendis.2025.101796_bib7","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1242\/jcs.02882","article-title":"Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP","volume":"119","author":"Dolzhanskaya","year":"2006","journal-title":"J Cell Sci"},{"issue":"15","key":"10.1016\/j.gendis.2025.101796_bib8","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00018-019-03145-x","article-title":"Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level","volume":"76","author":"Tewary","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.tibs.2011.09.001","article-title":"Versatility of PRMT5-induced methylation in growth control and development","volume":"36","author":"Karkhanis","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib10","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.celrep.2018.08.002","article-title":"PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes","volume":"24","author":"Hamard","year":"2018","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2020.12.010","article-title":"MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage","volume":"39","author":"Kalev","year":"2021","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.gendis.2025.101796_bib12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/emboj.2012.17","article-title":"Arginine methylation controls growth regulation by E2F-1","volume":"31","author":"Cho","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.gendis.2025.101796_bib13","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1038\/ncomms9419","article-title":"Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis","volume":"6","author":"Hu","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib14","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1172\/JCI85239","article-title":"Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia","volume":"126","author":"Jin","year":"2016","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb1413","article-title":"Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells","volume":"8","author":"Ancelin","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"17","key":"10.1016\/j.gendis.2025.101796_bib16","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1074\/jbc.M110.103911","article-title":"Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis","volume":"285","author":"Ren","year":"2010","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/cr.2010.56","article-title":"PRMT5 regulates golgi apparatus structure through methylation of the golgin GM130","volume":"20","author":"Zhou","year":"2010","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/0008-5472.CAN-15-1766","article-title":"Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth","volume":"76","author":"Liu","year":"2016","journal-title":"Cancer Res"},{"issue":"6278","key":"10.1016\/j.gendis.2025.101796_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib20","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1172\/JCI81749","article-title":"Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis","volume":"125","author":"Liu","year":"2015","journal-title":"J Clin Investig"},{"issue":"13","key":"10.1016\/j.gendis.2025.101796_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1834","article-title":"Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response","volume":"7","author":"Ma","year":"2021","journal-title":"Sci Adv"},{"issue":"551","key":"10.1016\/j.gendis.2025.101796_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5683","article-title":"PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity","volume":"12","author":"Kim","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-018-07884-6","article-title":"PRMT5 is essential for B cell development and germinal center dynamics","volume":"10","author":"Litzler","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/onc.2016.199","article-title":"PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells","volume":"36","author":"Banasavadi-Siddegowda","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib26","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1093\/nar\/gkae319","article-title":"PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells","volume":"52","author":"Vijayakumar","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"10.1016\/j.gendis.2025.101796_bib27","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/s41388-024-03049-6","article-title":"Arginine methylation of caspase-8 controls life\/death decisions in extrinsic apoptotic networks","volume":"43","author":"Wohlfromm","year":"2024","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.gendis.2025.101796_bib28","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.3390\/cancers13205136","article-title":"PRMT5: an emerging target for pancreatic adenocarcinoma","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gendis.2025.101796_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101016","article-title":"Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance","volume":"72","author":"Zhu","year":"2024","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.gendis.2025.101796_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112368","article-title":"Protein arginine N-methyltransferase 5 in colorectal carcinoma: insights into mechanisms of pathogenesis and therapeutic strategies","volume":"145","author":"Abumustafa","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib31","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.7150\/thno.42047","article-title":"PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.gendis.2025.101796_bib32","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1093\/nar\/gky461","article-title":"PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77\/CRL4B complex to promote tumorigenesis","volume":"46","author":"Liu","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101796_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccr.2010.08.012","article-title":"Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase","volume":"18","author":"Aggarwal","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2159-8290.CD-14-0625","article-title":"PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers","volume":"5","author":"Li","year":"2015","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib35","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41375-019-0489-6","article-title":"PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K\/AKT in lymphoma cells","volume":"33","author":"Zhu","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.gendis.2025.101796_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108614","article-title":"Chemical inhibitors targeting histone methylation readers","volume":"256","author":"Huang","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.gendis.2025.101796_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115456","article-title":"The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: from experimental study to clinical application","volume":"167","author":"Ning","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/13543776.2022.2163162","article-title":"An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022)","volume":"32","author":"Dong","year":"2022","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/neuonc\/nox206","article-title":"PRMT5 as a druggable target for glioblastoma therapy","volume":"20","author":"Banasavadi-Siddegowda","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib40","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gendis.2025.101796_bib41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12885-016-2632-3","article-title":"Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation","volume":"16","author":"Sheng","year":"2016","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17856","article-title":"PRMT5 activates KLF5 by methylation to facilitate lung cancer","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib43","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1111\/cas.14988","article-title":"An AKT\/PRMT5\/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth","volume":"112","author":"Liu","year":"2021","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib44","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/jcmm.14036","article-title":"Targeting PRMT5\/Akt signalling axis prevents human lung cancer cell growth","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib45","article-title":"PRMT5 enables robust STAT3 activation via arginine symmetric dimethylation of SMAD7","volume":"8","author":"Cai","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.gendis.2025.101796_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-016-0508-4","article-title":"GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer","volume":"15","author":"Sheng","year":"2016","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/onc.2016.205","article-title":"A TGF\u03b2-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"issue":"5 Pt A","key":"10.1016\/j.gendis.2025.101796_bib48","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.bbadis.2018.02.021","article-title":"Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells","volume":"1864","author":"Zakrzewicz","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.gendis.2025.101796_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2018.04.019","article-title":"Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family\/FGFR3 signaling","volume":"427","author":"Jing","year":"2018","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22088","article-title":"Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.2100523","article-title":"PRMT5 deficiency enforces the transcriptional and epigenetic programs of Klrg1+CD8+ terminal effector T cells and promotes cancer development","volume":"208","author":"Zheng","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2025.101796_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722188","article-title":"PRMT5 inhibition promotes PD-L1 expression and immuno-resistance in lung cancer","volume":"12","author":"Hu","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41467-023-36124-9","article-title":"Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma","volume":"14","author":"Salam","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib54","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41467-021-21204-5","article-title":"PRMT5 inhibition disrupts splicing and stemness in glioblastoma","volume":"12","author":"Sachamitr","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2025.101796_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.08.018","article-title":"Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma","volume":"32","author":"Braun","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1158\/0008-5472.CAN-13-0884","article-title":"Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma","volume":"74","author":"Yan","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib57","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-021-24240-3","article-title":"Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine","volume":"12","author":"Barekatain","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib58","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.celrep.2019.08.031","article-title":"A PRMT5-RNF168-SMURF2 axis controls H2AX proteostasis","volume":"28","author":"Du","year":"2019","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib59","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/cancers13051111","article-title":"Integrin \u03b1v\u03b23 engagement regulates glucose metabolism and migration through focal adhesion kinase (FAK) and protein arginine methyltransferase 5 (PRMT5) in glioblastoma cells","volume":"13","author":"Che","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib60","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/noab014","article-title":"Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma","volume":"23","author":"Otani","year":"2021","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib61","article-title":"Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib","volume":"4","author":"Banasavadi-Siddegowda","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib62","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.celrep.2017.11.096","article-title":"PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression","volume":"21","author":"Chiang","year":"2017","journal-title":"Cell Rep"},{"issue":"16","key":"10.1016\/j.gendis.2025.101796_bib63","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1158\/0008-5472.CAN-11-0458","article-title":"Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4","volume":"71","author":"Powers","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ijc.31909","article-title":"LKB1 regulates PRMT5 activity in breast cancer","volume":"144","author":"Lattouf","year":"2019","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib65","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41418-021-00793-0","article-title":"Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib66","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217248","article-title":"Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ER\u03b1+ breast cancer","volume":"15","author":"Poulard","year":"2023","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1016\/j.gendis.2025.101796_bib67","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.ymthe.2022.03.003","article-title":"PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer","volume":"30","author":"Wu","year":"2022","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006890","article-title":"PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis","volume":"11","author":"Wang","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib69","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/0008-5472.CAN-23-1899","article-title":"CircMMP2(6, 7) cooperates with \u03b2-catenin and PRMT5 to disrupt bone homeostasis and promote breast cancer bone metastasis","volume":"84","author":"Xu","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib70","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41467-021-21963-1","article-title":"Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.gendis.2025.101796_bib71","doi-asserted-by":"crossref","first-page":"11106","DOI":"10.1093\/nar\/gkx727","article-title":"The PRMT5\/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer","volume":"45","author":"Rengasamy","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib72","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/jcmm.16260","article-title":"Protein arginine methyltransferase 5 (PRMT5) activates WNT\/\u03b2-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3","volume":"25","author":"Shailesh","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-022-02400-7","article-title":"The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression","volume":"41","author":"Zhang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101796_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fimmu.2019.00174","article-title":"PRMT5 associates with the foxp3 homomer and when disabled enhances targeted p185erbB2\/neu tumor immunotherapy","volume":"10","author":"Nagai","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib75","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.3390\/ijms21103684","article-title":"Regulation of a PRMT5\/NF-\u03baB axis by phosphorylation of PRMT5 at serine 15 in colorectal cancer","volume":"21","author":"Hartley","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib76","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.7150\/thno.53023","article-title":"PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.gendis.2025.101796_bib77","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41388-023-02674-x","article-title":"PRMT5 methylating SMAD4 activates TGF-\u03b2 signaling and promotes colorectal cancer metastasis","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib78","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.18632\/aging.202407","article-title":"PRMT5 regulates colorectal cancer cell growth and EMT via EGFR\/Akt\/GSK3\u03b2 signaling cascades","volume":"13","author":"Yan","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib79","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-019-1487-3","article-title":"NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression","volume":"10","author":"Demetriadou","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113413","article-title":"PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1","volume":"422","author":"Chen","year":"2023","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074710","article-title":"PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.)","volume":"8","author":"Nicholas","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI95410","article-title":"SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth","volume":"128","author":"Tamiya","year":"2018","journal-title":"J Clin Investig"},{"issue":"36","key":"10.1016\/j.gendis.2025.101796_bib83","doi-asserted-by":"crossref","first-page":"17990","DOI":"10.1073\/pnas.1901323116","article-title":"Regulation of PRMT5-MDM4 axis is critical in the response to CDK4\/6 inhibitors in melanoma","volume":"116","author":"AbuHammad","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib84","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.gendis.2025.101796_bib85","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2025.101796_bib86","article-title":"Protein arginine methyltransferase 5 promotes esophageal squamous cell carcinoma proliferation and metastasis via LKB1\/AMPK\/mTOR signaling pathway","volume":"9","author":"Chen","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.gendis.2025.101796_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102626","article-title":"STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma","volume":"60","author":"Jiang","year":"2023","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12943-022-01598-6","article-title":"The circSPON2\/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression","volume":"21","author":"Yao","year":"2022","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib89","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/onc.2016.287","article-title":"Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.gendis.2025.101796_bib90","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1158\/0008-5472.CAN-20-1228","article-title":"Protein arginine methyltransferase 5 promotes pICln-dependent androgen receptor transcription in castration-resistant prostate cancer","volume":"80","author":"Beketova","year":"2020","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1535-7163.MCT-21-0103","article-title":"Targeting protein arginine methyltransferase 5 suppresses radiation-induced neuroendocrine differentiation and sensitizes prostate cancer cells to radiation","volume":"21","author":"Owens","year":"2022","journal-title":"Mol Cancer Therapeut"},{"issue":"18","key":"10.1016\/j.gendis.2025.101796_bib92","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.7150\/thno.59605","article-title":"PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib93","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/s41418-021-00786-z","article-title":"Snail\/PRMT5\/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition","volume":"28","author":"Gao","year":"2021","journal-title":"Cell Death Differ"},{"issue":"25","key":"10.1016\/j.gendis.2025.101796_bib94","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"45","key":"10.1016\/j.gendis.2025.101796_bib96","doi-asserted-by":"crossref","first-page":"28068","DOI":"10.1073\/pnas.2009899117","article-title":"Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells","volume":"117","author":"Wei","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib97","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jcmm.14894","article-title":"PRMT5 promotes epithelial-mesenchymal transition via EGFR-\u03b2-catenin axis in pancreatic cancer cells","volume":"24","author":"Ge","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib98","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov"},{"issue":"16","key":"10.1016\/j.gendis.2025.101796_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119168119","article-title":"Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer","volume":"119","author":"LaRue","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12964-019-0344-4","article-title":"PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis","volume":"17","author":"Qin","year":"2019","journal-title":"Cell Commun Signal"},{"issue":"23","key":"10.1016\/j.gendis.2025.101796_bib102","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2023114558","article-title":"MST2 methylation by PRMT5 inhibits hippo signaling and promotes pancreatic cancer progression","volume":"42","author":"Sun","year":"2023","journal-title":"EMBO J"},{"issue":"16","key":"10.1016\/j.gendis.2025.101796_bib103","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/onc.2015.270","article-title":"Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells","volume":"35","author":"Calabretta","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ijc.28327","article-title":"Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma","volume":"134","author":"Unruh","year":"2014","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41594-019-0313-z","article-title":"PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia","volume":"26","author":"Radzisheuskaya","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib106","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s43018-022-00384-z","article-title":"Dysregulation and therapeutic targeting of RNA splicing in cancer","volume":"3","author":"Stanley","year":"2022","journal-title":"Nat Cancer"},{"issue":"22_suppl ment","key":"10.1016\/j.gendis.2025.101796_bib107","article-title":"Abstract PO-007: PRMT5 inhibition sensitizes pancreatic cancer to gemcitabine in orthotopic and metastatic murine models","volume":"80","author":"Kane","year":"2020","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib108","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1038\/s41467-022-32591-8","article-title":"The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma","volume":"13","author":"Renouf","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib109","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial","volume":"5","author":"O'Reilly","year":"2019","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib110","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2017.01.019","article-title":"PRMT5-dependent methylation of the TIP60 coactivator RUVBL1 is a key regulator of homologous recombination","volume":"65","author":"Clarke","year":"2017","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-21-0620","article-title":"SAM-Competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance","volume":"21","author":"Jensen-Pergakes","year":"2022","journal-title":"Mol Cancer Therapeut"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib113","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1535-7163.MCT-21-0367","article-title":"Discovery and pharmacological characterization of JNJ-64619178, a novel small-molecule inhibitor of PRMT5 with potent antitumor activity","volume":"20","author":"Brehmer","year":"2021","journal-title":"Mol Cancer Therapeut"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib114","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","article-title":"MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer","volume":"13","author":"Engstrom","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.gendis.2025.101796_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215594","article-title":"Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer","volume":"532","author":"Yang","year":"2022","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.gendis.2025.101796_bib116","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/acsmedchemlett.8b00014","article-title":"LLY-283, a potent and selective inhibitor of arginine methyltransferase 5, PRMT5, with antitumor activity","volume":"9","author":"Bonday","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"13_suppl ment","key":"10.1016\/j.gendis.2025.101796_bib117","article-title":"Abstract LB003: fragment based discovery of MRTX9768, a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP\/CDKN2A-deleted tumors","volume":"81","author":"Smith","year":"2021","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib118","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302009","article-title":"PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer","volume":"6","author":"Noureddine","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib119","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.3390\/ijms23094806","article-title":"Novel chemicals derived from tadalafil exhibit PRMT5 inhibition and promising activities against breast cancer","volume":"23","author":"Yang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2025.101796_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111166","article-title":"Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy","volume":"119","author":"Abumustafa","year":"2024","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib121","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41467-024-46495-2","article-title":"PRMT5 is an actionable therapeutic target in CDK4\/6 inhibitor-resistant ER+\/RB-deficient breast cancer","volume":"15","author":"Lin","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.245","article-title":"PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1","volume":"4","author":"Xie","year":"2023","journal-title":"MedComm"},{"issue":"12","key":"10.1016\/j.gendis.2025.101796_bib123","article-title":"PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition","volume":"4","author":"Li","year":"2023","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib124","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12885-023-11260-z","article-title":"Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer","volume":"23","author":"O'Brien","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-022-00299-4","article-title":"Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer","volume":"10","author":"Shen","year":"2022","journal-title":"Cancer Metabol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250226","article-title":"Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression","volume":"53","author":"Zhou","year":"2023","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib127","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gendis.2022.04.001","article-title":"Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue","volume":"10","author":"Prabhu","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.gendis.2025.101796_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114657","article-title":"New therapy for pancreatic cancer based on extracellular vesicles","volume":"162","author":"Araujo-Abad","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib129","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151353","article-title":"Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype","volume":"7","author":"Orben","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15698\/cst2020.08.228","article-title":"PRMT5 function and targeting in cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Cell Stress"},{"issue":"38","key":"10.1016\/j.gendis.2025.101796_bib131","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1073\/pnas.1706978114","article-title":"Epigenetic control via allosteric regulation of Mammalian protein arginine methyltransferases","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib132","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1093\/nar\/gkz200","article-title":"PRMT1 loss sensitizes cells to PRMT5 inhibition","volume":"47","author":"Gao","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib133","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-019-1064-8","article-title":"The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.gendis.2025.101796_bib134","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1073\/pnas.1522372113","article-title":"Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNF\u03b1\/NF-\u03baB response","volume":"113","author":"Reintjes","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2013.08.039","article-title":"Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1","volume":"52","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw4640","article-title":"Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control","volume":"5","author":"Roworth","year":"2019","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib137","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ccell.2018.12.010","article-title":"Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases","volume":"35","author":"Connor","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.gendis.2025.101796_bib138","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0021-9258(17)49877-2","article-title":"Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma","volume":"295","author":"Karkhanis","year":"2020","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib139","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41467-018-04006-0","article-title":"The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib140","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acs.jproteome.3c00724","article-title":"ETD-based proteomic profiling improves arginine methylation identification and reveals novel PRMT5 substrates","volume":"23","author":"Lu","year":"2024","journal-title":"J Proteome Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101796_bib141","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer","volume":"4","author":"Li","year":"2023","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib142","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1038\/s41467-022-33137-8","article-title":"TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma","volume":"13","author":"Erazo","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.gendis.2025.101796_bib143","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.2022019419","article-title":"PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma","volume":"142","author":"Sloan","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.gendis.2025.101796_bib144","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41419-020-02771-9","article-title":"PRMT5 promotes cancer cell migration and invasion through the E2F pathway","volume":"11","author":"Barczak","year":"2020","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/1878-0261.13702","article-title":"Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma","volume":"19","author":"Bate-Eya","year":"2025","journal-title":"Mol Oncol"},{"issue":"33","key":"10.1016\/j.gendis.2025.101796_bib146","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1073\/pnas.1311784110","article-title":"PRMT5 dimethylates R30 of the p65 subunit to activate NF-\u03baB","volume":"110","author":"Wei","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib147","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/cvr\/cvad080","article-title":"Protein arginine methyltransferase 5-mediated arginine methylation stabilizes Kruppel-like factor 4 to accelerate neointimal formation","volume":"119","author":"Liu","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101796_bib148","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101796_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044033","article-title":"Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells","volume":"7","author":"Gu","year":"2012","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.gendis.2025.101796_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9589","article-title":"A PRMT5-ZNF326 axis mediates innate immune activation upon replication stress","volume":"10","author":"Hoang","year":"2024","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.gendis.2025.101796_bib151","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncb2158","article-title":"Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation","volume":"13","author":"Hsu","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101796_bib152","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.devcel.2018.06.025","article-title":"Loss of PRMT5 promotes PDGFR\u03b1 degradation during oligodendrocyte differentiation and myelination","volume":"46","author":"Calabretta","year":"2018","journal-title":"Dev Cell"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110940","article-title":"Interplay between symmetric arginine dimethylation and ubiquitylation regulates TDP1 proteostasis for the repair of topoisomerase I-DNA adducts","volume":"39","author":"Bhattacharjee","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib154","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1093\/nar\/gky291","article-title":"PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes","volume":"46","author":"Rehman","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"10.1016\/j.gendis.2025.101796_bib155","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1182\/bloodadvances.2023009906","article-title":"PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma","volume":"7","author":"Brown-Burke","year":"2023","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.gendis.2025.101796_bib156","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1093\/nar\/gkq1264","article-title":"A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage","volume":"39","author":"He","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101796_bib157","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.18632\/aging.102760","article-title":"PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP\/p21 axis","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"23","key":"10.1016\/j.gendis.2025.101796_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314832","article-title":"SRSF3 and HNRNPH1 regulate radiation-induced alternative splicing of protein arginine methyltransferase 5 in hepatocellular carcinoma","volume":"23","author":"Wen","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101796_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72942-3","article-title":"PRMT5-mediated methylation of YBX1 regulates NF-\u03baB activity in colorectal cancer","volume":"10","author":"Hartley","year":"2020","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.gendis.2025.101796_bib160","doi-asserted-by":"crossref","first-page":"e00302","DOI":"10.1128\/MCB.00302-20","article-title":"WD repeat domain 77 protein regulates translation of E2F1 and E2F3 mRNA","volume":"40","author":"Altayyar","year":"2020","journal-title":"Mol Cell Biol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:32:43Z","timestamp":1772904763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":160,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2352304225002855"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101796","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101796"}}